Injection tube for jet injection device
Abstract
A non-metal, polymeric tubular device for delivering a therapeutic fluid to a treatment site within a patient. The non-metal, polymeric tubular device can be fabricated using suitable high strength polymers and in some versions can be reinforced through the inclusion of reinforcement materials or braiding. The non-metal, polymeric tubular device can be fabricated so as to have a burst strength exceeding at least about 2,000 psi. The non-metal, polymeric tubular device can be fabricated so as to have distention properties, wherein an orifice or jet port located at a distal end of the polymeric tubular device retains its shape and/or size without suffering swelling that can have a detrimental impact on a fluid jet used to deliver the therapeutic fluid at the treatment site.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A method for delivering a therapeutic fluid to a treatment location with a non-metal, polymeric tubular device comprising:
providing a non-metal, polymeric applicator body having a distal end and a proximal connection end, wherein an administration orifice is positioned proximate the distal end, and wherein the applicator body comprises polymer selected from the group consisting of: a polyimide polymer, a polyetherimide polymer, and a linear aromatic polymer; positioning the administration orifice proximate a treatment location; and generating a fluid jet through the administration orifice for dispensing a therapeutic fluid at the treatment location.
18 . The method of claim 17 , further wherein:
the non-metal, polymeric applicator body comprises reinforcing materials.
19 . The method of claim 17 , further wherein:
the non-metal, polymeric applicator body comprises reinforcing fiber.
20 . The method of claim 17 , wherein generating the fluid jet comprises pressurizing the therapeutic fluid with an injector attached to the proximal connection end.
21 . The method of claim 17 wherein the applicator body has a burst pressure of at least about 2,000 psi.
22 . The method of claim 17 wherein the applicator body comprises polyether ether ketone.
23 . The method of claim 17 wherein the applicator body is formed of non-reinforced polyether ether ketone polymer.
24 . The method of claim 17 wherein the applicator body is formed of reinforced polyether ether ketone polymer.
25 . The method of claim 17 comprising placing the applicator body in a patient's urogenital tract.
26 . The method of claim 17 comprising passing the applicator body within a urethra.
27 . The method of claim 17 wherein the treatment location comprises tissue of a bladder.
28 . The method of claim 17 comprising injecting therapeutic fluid into tissue at the treatment location.
29 . The method of claim 17 wherein the applicator body comprises a polymeric tubular device comprising sidewalls defining a lumen, the sidewalls and lumen terminating at a distal lumen end, wherein the distal lumen end is closed and the administration orifice is a bore through the sidewall, the bore being located along a length of the tubular device on a proximal side of the distal lumen end.
30 . The method of claim 29 wherein the applicator body comprises polyether ether ketone, the method comprising placing the applicator body in a patient's urethra and injecting therapeutic fluid into tissue at the treatment location.
31 . The method of claim 30 wherein the treatment location comprises tissue of a bladder.
32 . A method for delivering a therapeutic fluid to a treatment location with a non-metal, polymeric tubular device comprising:
providing a non-metal, polymeric applicator body having a distal end and a proximal connection end, wherein an administration orifice is positioned proximate the distal end; positioning the administration orifice proximate a treatment location; and generating a fluid jet comprising therapeutic fluid through the administration orifice to inject therapeutic fluid into tissue at the treatment location.
33 . The method of claim 32 comprising placing the applicator body in a patient's urogenital tract.
34 . The method of claim 32 wherein the treatment location comprises tissue of a bladder.
35 . The method of claim 32 wherein the applicator body comprises a polymeric tubular device comprising sidewalls defining a lumen, the sidewalls and lumen terminating at a distal lumen end, wherein the distal lumen end is closed and the administration orifice is a bore through the sidewall, the bore being located along a length of the tubular device on a proximal side of the distal lumen end.
36 . The method of claim 35 wherein the applicator body comprises polyether ether ketone, the method comprising placing the applicator body in a patient's urethra and injecting therapeutic fluid into tissue at the treatment location.
37 . A method for delivering a therapeutic fluid to a treatment location with a non-metal, polymeric tubular device comprising:
providing a non-metal, polymeric applicator body having a distal end and a proximal connection end, wherein an administration orifice is positioned proximate the distal end, and wherein the applicator body has a burst pressure of at least about 2,000 psi; positioning the administration orifice proximate a treatment location; and generating a fluid jet through the administration orifice for dispensing a therapeutic fluid at the treatment location.
38 . The method of claim 37 comprising placing the applicator body in a patient's urogenital tract.
39 . The method of claim 37 wherein the treatment location comprises tissue of a bladder.
40 . The method of claim 37 wherein the applicator body comprises a polymeric tubular device comprising sidewalls defining a lumen, the sidewalls and lumen terminating at a distal lumen end, wherein the distal lumen end is closed and the administration orifice is a bore through the sidewall, the bore being located along a length of the tubular device on a proximal side of the distal lumen end.
41 . The method of claim 37 wherein the applicator body comprises polyether ether ketone, the method comprising placing the applicator body in a patient's urethra and injecting therapeutic fluid into tissue at the treatment location.
42 . The method of claim 17 wherein during generating a fluid jet through the administration orifice, dimensional characteristics of the administration orifice remain constant under the influence of the fluid jet.
43 . The method of claim 32 wherein during generating a fluid jet through the administration orifice, dimensional characteristics of the administration orifice remain constant under the influence of the fluid jet.
44 . The method of claim 37 wherein during generating a fluid jet through the administration orifice, dimensional characteristics of the administration orifice remain constant under the influence of the fluid jet.Join the waitlist — get patent alerts
Track US2009259213A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.